71952-91-5

Usage

Uses

Used in Pharmaceutical Development:
(4Z,6E,10E)-19-(cyclopropylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate is used as a potential pharmaceutical candidate for the development of new drugs. Its unique structure and functional groups may allow it to interact with specific biological targets, making it a valuable compound for the treatment of various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (4Z,6E,10E)-19-(cyclopropylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate is used as a starting point for the design and synthesis of new bioactive molecules. Its intricate structure and functional groups can be modified to explore various chemical and biological properties, potentially leading to the discovery of novel therapeutic agents.
Used in Drug Delivery Systems:
(4Z,6E,10E)-19-(cyclopropylamino)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate may also be utilized in the development of drug delivery systems. Its carbamate group could be exploited for conjugation to drug carriers, such as nanoparticles or liposomes, to improve the delivery and bioavailability of therapeutic agents.
Used in Chemical Synthesis:
This complex molecule can be used as an intermediate or building block in the synthesis of other organic compounds. Its unique structure and functional groups make it a valuable tool for chemists working on the development of new materials or pharmaceuticals.